نتائج البحث - "Yumi Asukai"

المصدر: Urowitz, M B, Aranow, C, Asukai, Y, Bass, D L, Bruce, I N, Chauhan, D, Dall'Era, M, Furie, R, Fox, N L, Gilbride, J A, Hammer, A, Ginzler, E M, Gonzalez-Rivera, T, Levy, R A, Merrill, J T, Quasny, H, Roth, D A, Stohl, W, van Vollenhoven, R, Wallace, D J & Petri, M 2022, ' Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus ', Arthritis Care and Research, vol. 74, no. 11, pp. 1822-1828 . https://doi.org/10.1002/acr.24901

مصطلحات موضوعية: Adult, Treatment Outcome, Rheumatology, B-Cell Activating Factor, Humans, Lupus Erythematosus, Systemic, Antibodies, Monoclonal, Lupus Nephritis, Glucocorticoids

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c81a899c9b46ed97a967794594c7bb5
http://www.scopus.com/inward/record.url?scp=85135523522&partnerID=8YFLogxK

View record at Wiley

4

Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic

المؤلفون: Louis P. Garrison, Peter J. Neumann, Daniel A. Ollendorf, Yumi Asukai, Benjamin P. Geisler, Andrew Briggs

المصدر: PharmacoEconomics. 39:1201-1208

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf200026ce0eb8c035fa775ffbc13be3
https://doi.org/10.1007/s40273-021-01088-5

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

5

دورية أكاديمية

Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic

المؤلفون: Yumi Asukai, Andrew Briggs, Louis P. Garrison, Benjamin P. Geisler, Peter J. Neumann, Daniel A. Ollendorf

المصدر: Springer, PharmacoEconomics. 39(11):1201-1208

الإتاحة: https://ideas.repec.org/a/spr/pharme/v39y2021i11d10.1007_s40273-021-01088-5.html

6

External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD)

المؤلفون: Andrew Briggs, Nancy Risebrough, Yumi Asukai, Martine Hoogendoorn, Ryan N. Hansen, Reiner Leidl, Maureen P.M.H. Rutten-van Mölken, Talitha L Feenstra, Yevgeniy Samyshkin, Margarethe Wacker

المساهمون: Methods in Medicines evaluation & Outcomes research (M2O), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Value, Affordability and Sustainability (VALUE), Health Technology Assessment (HTA)

المصدر: Value in Health, 20(3), 397-403. ELSEVIER SCIENCE INC
Value in Health, 20(3), 397-403. Elsevier Ltd.
Value Health 20, 397-403 (2017)

مصطلحات موضوعية: Male, TORCH, Exacerbation, Cost effectiveness, Cost-Benefit Analysis, COST-EFFECTIVENESS, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Bronchodilator, Medicine, 030212 general & internal medicine, Salmeterol Xinafoate, Randomized Controlled Trials as Topic, BRONCHODILATOR, Aged, 80 and over, COPD, 030503 health policy & services, Health Policy, Mortality rate, Tiotropium bromide, Middle Aged, Bronchodilator Agents, Economics, Medical, Treatment Outcome, DYNAMIC POPULATION-MODEL, Female, Quality-Adjusted Life Years, 0305 other medical science, Models, Econometric, medicine.drug, INTERVENTIONS, medicine.medical_specialty, medicine.drug_class, Decision Making, ROFLUMILAST, Placebo, 03 medical and health sciences, external validation, Internal medicine, Humans, Computer Simulation, Tiotropium Bromide, Aged, model, business.industry, Public Health, Environmental and Occupational Health, Copd, Cost-effectiveness, External Validation, Model, medicine.disease, Quality-adjusted life year, Physical therapy, Fluticasone, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16211f8dd569f169261d6ea586b04b68
https://hdl.handle.net/11370/e5a05d56-64ab-44c3-8b9b-6763adb975fc

View record from ScienceDirect

Full Text via ClinicalKey

7

Impact of moderate and severe exacerbations in severe COPD patients

المؤلفون: Yumi Asukai, Claire Gait, Katie Pascoe, Dmitry V Galkin, Necdet B Gunsoy

المصدر: Clinical Problems.

مصطلحات موضوعية: Disease status, COPD, medicine.medical_specialty, business.industry, Severe exacerbation, macromolecular substances, Severe copd, medicine.disease, respiratory tract diseases, Quality of life, Internal medicine, Eosinophilic, Medicine, In patient, business, Mepolizumab, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::26b8a8cfbb293d65cd0ab962eb5fd462
https://doi.org/10.1183/13993003.congress-2018.pa3865

8

The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System

المؤلفون: Yumi Asukai, Gerardo Machnicki, Luis Fernando Garcés Giraldo, Juan Guillermo Ariza, Laura Mungapen, Per-Olof Thuresson, Matthias Kraemer

المصدر: Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
Repositorio Universidad de la Sabana
Universidad de la Sabana
instacron:Universidad de la Sabana